Company news
Polynovo Limited (ASX:PNV) news
Polynovo Limited news releases on 6ix. Latest, Aug 25, 2026: FY26 Full Year Results Investor Presentation
Press releases & updates
FY26 Full Year Results Investor Presentation
August 25, 2026
PolyNovo FY26 Trading Update
July 22, 2026
Response to ASX Price Query
May 14, 2026
Appendix 4D & H1 FY26 Financial Statements
February 20, 2026
1H FY26 Results Presentation
February 20, 2026
1H26 Trading Result (unaudited)
January 18, 2026
Trading Results Q1 FY26 (unaudited)
October 19, 2025
CEO appointment - Mr. Bruce Peatey
October 16, 2025
Chronic diabetic-related wound study results
September 12, 2025
Trading Halt
September 12, 2025
Pause in Trading
September 12, 2025
S&P DJI Announces September 2025 Quarterly Rebalance
September 5, 2025
U.S. Medicare Reimbursement Proposal
September 2, 2025
FY25 Results Presentation
August 25, 2025
Appendix 4E and FY25 Financial Statements
August 25, 2025
FY25 Trading Result (unaudited)
July 29, 2025
BTM delivers positive First in Man results in Cell Therapies
May 13, 2025
First A$11m sales month
April 9, 2025
Change of CEO
March 10, 2025
Additional response to articles in 'Margin Call'
March 7, 2025
Response to article in 'Margin Call'
March 6, 2025
1H FY25 Results Presentation
February 24, 2025
Appendix 4D & 1H FY25 Report
February 24, 2025
1H FY25 Trading Result (unaudited)
January 17, 2025
First $A10m sales month
December 22, 2024
Appendix 4E and FY24 Financial Statements
August 23, 2024
FY24 Trading Result (unaudited)
July 23, 2024
First $A9M sales month and $A10M revenue month
May 7, 2024
India update
March 3, 2024
1H FY24 Results Presentation
February 27, 2024
Appendix 4D & 1H FY24 Report
February 27, 2024
1H24 Trading Result (unaudited)
January 22, 2024
First $A8M sales month and $A9M revenue month
December 6, 2023
AGM - Chairman and CEO address to shareholders
November 3, 2023
BARDA increases funding US$10M
October 1, 2023
YTD August 2023 Trading Update
September 25, 2023
FY23 Results Presentation
August 23, 2023
Appendix 4E and FY23 Financial Statements
August 23, 2023
First ever A$7M Sales Month
June 6, 2023
NovoSorb MTX First Sales and March 2023 $6m Revenue
May 2, 2023
S&P DJI Announces March 2023 Quarterly Rebalance
March 3, 2023
1H FY23 Results Presentation
February 22, 2023
Appendix 4D and 1H FY23 Report
February 22, 2023
1H23 Indicative Trading Result (unaudited)
January 15, 2023
Successful Completion of Share Purchase Plan
December 16, 2022
Share Purchase Plan (SPP) Offer
November 29, 2022
Completion of $30m Institutional Placement
November 22, 2022
Capital Raising
November 22, 2022
Investor Presentation
November 22, 2022
Chairman and CEO - AGM address to shareholders
October 28, 2022